The prognostic impact of ICOS expression is inconsistent across various tumour types (e.g., melanoma, colorectal cancer, breast cancer, gastric cancer, and renal cell carcinoma), and these clinical findings support the dual role of ICOS in carcinogenesis8. The gene discussed is ICOS; the disease is melanoma.